Annual ROE
383.46%
+871.99%+178.49%
April 30, 2024
Summary
- As of February 8, 2025, ALZN annual return on equity is 383.46%, with the most recent change of +871.99% (+178.49%) on April 30, 2024.
- During the last 3 years, ALZN annual ROE has risen by +634.17% (+252.95%).
- ALZN annual ROE is now at all-time high.
Performance
ALZN ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
542.00%
+266.93%+97.04%
October 31, 2024
Summary
- As of February 8, 2025, ALZN quarterly return on equity is 542.00%, with the most recent change of +266.93% (+97.04%) on October 31, 2024.
- Over the past year, ALZN quarterly ROE has increased by +266.93% (+97.04%).
- ALZN quarterly ROE is now -74.54% below its all-time high of 2128.47%, reached on January 31, 2021.
Performance
ALZN Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ALZN ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +178.5% | +97.0% |
| 3 y3 years | +252.9% | +97.0% |
| 5 y5 years | +125.0% | +97.0% |
ALZN ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +178.5% | -56.1% | +154.6% |
| 5 y | 5-year | at high | +125.0% | -74.5% | +138.5% |
| alltime | all time | at high | +125.0% | -74.5% | +138.5% |
Alzamend Neuro ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Oct 2024 | - | 542.00%(+97.0%) |
| Jul 2024 | - | 275.07%(-33.3%) |
| Apr 2024 | 383.46%(-178.5%) | 412.19%(-66.6%) |
| Jan 2024 | - | 1235.94%(-224.5%) |
| Oct 2023 | - | -992.86%(+183.9%) |
| Jul 2023 | - | -349.70%(+69.7%) |
| Apr 2023 | -488.53%(+427.6%) | -206.11%(+30.7%) |
| Jan 2023 | - | -157.65%(+41.8%) |
| Oct 2022 | - | -111.21%(+5.3%) |
| Jul 2022 | - | -105.65%(+14.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Apr 2022 | -92.59%(-63.1%) | -92.11%(+0.0%) |
| Jan 2022 | - | -92.10%(-19.3%) |
| Oct 2021 | - | -114.08%(+1.0%) |
| Jul 2021 | - | -113.00%(-92.0%) |
| Apr 2021 | -250.71%(-53.3%) | -1407.70%(-166.1%) |
| Jan 2021 | - | 2128.47%(-545.3%) |
| Oct 2020 | - | -478.00%(+52.6%) |
| Jul 2020 | - | -313.20%(+104.8%) |
| Apr 2020 | -536.72%(-65.0%) | -152.95% |
| Apr 2019 | -1534.40% | - |
FAQ
- What is Alzamend Neuro annual return on equity?
- What is the all time high annual ROE for Alzamend Neuro?
- What is Alzamend Neuro annual ROE year-on-year change?
- What is Alzamend Neuro quarterly return on equity?
- What is the all time high quarterly ROE for Alzamend Neuro?
- What is Alzamend Neuro quarterly ROE year-on-year change?
What is Alzamend Neuro annual return on equity?
The current annual ROE of ALZN is 383.46%
What is the all time high annual ROE for Alzamend Neuro?
Alzamend Neuro all-time high annual return on equity is 383.46%
What is Alzamend Neuro annual ROE year-on-year change?
Over the past year, ALZN annual return on equity has changed by +871.99% (+178.49%)
What is Alzamend Neuro quarterly return on equity?
The current quarterly ROE of ALZN is 542.00%
What is the all time high quarterly ROE for Alzamend Neuro?
Alzamend Neuro all-time high quarterly return on equity is 2128.47%
What is Alzamend Neuro quarterly ROE year-on-year change?
Over the past year, ALZN quarterly return on equity has changed by +266.93% (+97.04%)